Iman Almansour
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults (NCT05171946) | Iman Almansour | 2022-11-20 |
Track Iman Almansour automatically
Every clearance here is in the API, with alerts when new ones post.